Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Odessa American
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar 5, 2021–
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar 5, 2021–
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan. TAK-919 is Takedas development code for Modernas COVID-19 vaccine…
Continue Reading